Details for 2016779363
Up to date per 01.04.2026
Actions
Details for 2016779363
Granted/Registered
European Patent
21.02.2018 A
01.01.2020 B1
14.04.2015
US
201562147427 P
A61K 31/277 20060101AFI20190805BHEP
Owner
Milestone Pharmaceuticals Inc.1111 Dr. Frederik-Philips Boulevard Suite 420 Saint-Laurent, Québec H4M 2X6CA
Representative
Representative
Häupl & Ellmeyer KG PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT
Inventor
MAGUIRE, Martin P.70 US Oval, Apt 413 Plattsburgh, NY 12903US
Information about Fees